Thu, April 13, 2023
Wed, April 12, 2023
Tue, April 11, 2023
Mon, April 10, 2023
Fri, April 7, 2023
Thu, April 6, 2023

Ami Fadia Reiterated (BIIB) at Strong Buy and Held Target at $325 on, Apr 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-325-on-apr-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ami Fadia of Needham, Reiterated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $325 on, Apr 11th, 2023.

Ami has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 0 agree with Ami's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Ami


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $325 on, Thursday, March 23rd, 2023
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $333 on, Thursday, February 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $340 on, Thursday, February 16th, 2023
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $310 on, Thursday, February 16th, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $351 on, Thursday, February 16th, 2023
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $315 on, Thursday, February 16th, 2023

Publication Contributing Sources